LONGEFI
Science

Gene therapy

Editing or adding genetic instructions directly inside the body.

What it is

In vivo editing has moved from concept to multi-year durable human data. For longevity, the important variable is not the first indication but whether delivery and safety generalise to preventive use.

Key mechanisms and technologies

  • In vivo CRISPR
  • Base editing
  • Lipid nanoparticle delivery
  • Redosing strategies

Published LONGEFI developments are listed chronologically in the News archive.